Grants
Sujit Basu, MD, PhD, professor of Pathology, has received a five-year, $1.5 million grant (HL131405) from the National Heart, Lung and Blood Institute titled “Role of Chebulinic Acid in Angiogenesis.
William Carson III, MD, professor in the Division of Surgical Oncology at Ohio State and associate director for clinical research at the OSUCCC – James, is overseeing a $2.5 million, five-year, National Cancer Institute (NCI) grant (CA186712) titled “UM1 Supplement for Early Therapeutic Trials With Phase 2 Intent.”
The Department of Defense awarded a $1.5 million, three-year Breast Cancer Research Program Breakthrough Award to Ramesh Ganju, PhD, professor and vice chair of Pathology, and Xue-Feng Bai, MD, PhD, associate professor of Pathology, for a project titled “CNR2: A Novel Therapeutic Target Against Aggressive and Metastatic Breast Cancer.”
Craig Hofmeister, MD, MPH, associate professor in the Division of Hematology, has received a five-year, $2.3 million NCI grant (CA201382) titled “Overcoming Imid Resistance in Myeloma.” Also, Hofmeister is co-principal investigator for a $2.74 million, five-year NCI grant for a project titled “Reolysin-Based Combination Therapy in Relapsed Multiple Myeloma.”
Balveen Kaur, PhD, professor of Neurological Surgery and associate director for shared resources at the OSUCCC – James, has received a five-year, $2 million NCI grant (CA150153) titled “Enhancing Viral Oncolysis with Vasculostatin Gene Delivery.”
Michael Tweedle, PhD, and Michael Knopp, MD, PhD, professors in the Department of Radiology, along with Thomas Rosol, DVM, PhD, professor of Veterinary Biosciences, have received a four-year, $2.33 million grant from the National Institute of Biomedical Imaging and Bioengineering to study an image-guided transcatheter peptide receptor radiotherapy for prostate cancer.
Emeritus professor Altaf Wani, PhD, and research assistant professor Qianzheng Zhu, PhD, both of the Department of Radiology, have received a five-year, $2.26 million grant from the National Institute of Environmental Health Sciences to study cross-talk between DNA damage responses.
Terence Williams, MD, PhD, assistant professor of Radiation Oncology, was awarded a five-year, $2 million NCI grant (CA198128) titled “Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer.”
The Harry T. Mangurian Jr. Foundation is donating $5 million to fund the Drug Development Institute and strategic cancer research initiatives at the OSUCCC – James, and to establish the Human Performance Innovation Initiative.
Awards and Honors
Michael A. Caligiuri, MD, director of the OSUCCC and CEO of The James, Sheldon Retchin, MD, MSPH, CEO of The Ohio State University Wexner Medical Center, and Steven Allen, MD, CEO of Nationwide Children’s Hospital, were recognized in the 2016 list of 110 physician leaders to know by Becker’s Hospital Review.
Arnab Chakravarti, MD, professor and chair of Radiation Oncology, received the 2016 Lifetime Achievement Award from the Society of Asian-American Scientists in Cancer Research for seminal research that has advanced the treatment of brain tumors.
Lanchun Lu, PhD, assistant professor of Radiation Oncology, received the 2016 ASTRO Basic/Translational Senior Investigator Award from the American Society for Radiation Oncology for innovative work on Endoscopic 3-D OCT-Guided Brachytherapy for Early Stag Pancreatic Cancers.
The James Cancer Hospital and Solove Research Institute is among 14 institutions worldwide that were named as Designated Centres of Integrated Oncology and Palliative Care by the European Society for Medical Oncology. The James also earned a 2016 Press Ganey Guardian of Excellence Award for Patient Experience in Inpatient Care and HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems).
The American Nurses Credentialing Center's Commission on Accreditation awarded “Accreditation with Distinction” status to The James Oncology and Critical Care Advanced Practice Fellowship. Only organizations that demonstrate no deficiencies requiring a progress report achieve this status.
The Ohio State University Wexner Medical Center received the 2016 Grace Award from the American Health Information Management Association. The award honors health care delivery organizations that demonstrate outstanding, innovative approaches to using health information management as a way to deliver high-quality care to patients. Also, for the fourth consecutive year, the OSUWMC was among 13 academic medical centers nationwide to win Vizient’s 2016 Bernard A. Birnbaum, MD, Quality Leadership Award for demonstrating superior performance.
Faculty and Programs
Peixuan Guo, PhD, a top nanobiotechnology expert, was recruited from the University of Kentucky to the Ohio State College of Pharmacy. He is a member of the OSUCCC – James Translational Therapeutics Program.
K. Craig Kent, MD, an internationally recognized vascular surgeon, is the new dean of The Ohio State University College of Medicine. He came to Ohio State from the University of Wisconsin School of Medicine and Public Health.
Dean Lee, MD, PhD, is the new director of the Cellular Therapy and Cancer Immunotherapy Program at Nationwide Children’s Hospital. Lee, recruited to Ohio State from The University of Texas MD Anderson Cancer Center, is also director of cellular therapy at the OSUCCC – James.
Stephen Lessnick, MD, PhD, has joined The Ohio State University College of Medicine and Nationwide Children’s Hospital as director of the Center for Childhood Cancer and Blood Disorders. He is a member of the OSUCCC – James Molecular Biology and Cancer Genetics Program.
Elaine Mardis PhD, and Rick Wilson, PhD, who formerly directed the McDonnell Genome Institute at Washington University in St. Louis, have joined The Ohio State University College of Medicine and Nationwide Children’s Hospital to lead a new genomics institute. Mardis is also a member of the OSUCCC – James Translational Therapeutics Program.
Timothy Pawlik, MD, MPH, PhD, a renowned surgeon and liver cancer expert, is the new chair of the Department of Surgery. Pawlik came to Ohio State from Johns Hopkins Hospital Department of Surgery.
CHERYL TAYLORE LEE, MD, a prominent expert in bladder cancer, is the new chair of the Department of Urology. Lee came to Ohio State from the University of Michigan.
Leadership Activities and Appointments
John C. Byrd, MD, Distinguished University Professor, director of the Division of Hematology at Ohio State, and co-leader of the OSUCCC – James Leukemia Research Program, was elected a councilor for the American Society of Hematology (ASH).
Maura L. Gillison, MD, PhD, professor in the Division of Medical Oncology, the Jeg Coughlin Chair in Cancer Research, and a member of the OSUCCC – James Cancer Control Program, has been elected to the National Academy of Medicine for her contributions to the fields of cancer biology, tumor virology and epidemiology.
Maryam Lustberg, MD, MPH, assistant professor in the Division of Medical Oncology and a member of the OSUCCC – James Cancer Control Program, has been appointed vice chair of the Neurological Complications Study Group within the Multinational Association of Supportive Care in Cancer.
Douglas Martin, MD, associate professor of Radiation Oncology, has been appointed as physician chair of the American Society for Therapeutic Radiology and Oncology’s APEX Accreditation Committee.
Electra Paskett, PhD, MSPH, associate director for population sciences and leader of the OSUCCC – James Cancer Control Program was appointed by President Barack Obama to the National Cancer Advisory Board. Paskett also holds the Marion N. Rowley Chair in Cancer Research at Ohio State and directs the Division of Cancer Prevention and Control.